Get started
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETFAmplify ETF Trust Amplify Weight Loss Drug & Treatment ETFAmplify ETF Trust Amplify Weight Loss Drug & Treatment ETF

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF

No trades
See on Supercharts
Overview Analysis
Holdings
News Discussions Technicals Seasonals

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF holdings


As of July 28, 2025
Symbol
Weight %
Shares
Market value
L
LLYEli Lilly and Company
12.62%
‪481.00‬
‪‪388.70 K‬‬USD
N
NVONovo Nordisk A/S Sponsored ADR Class B
10.78%
‪‪4.81 K‬‬
‪‪331.96 K‬‬USD
R
REGNRegeneron Pharmaceuticals, Inc.
7.22%
‪398.00‬
‪‪222.33 K‬‬USD
A
AMGNAmgen Inc.
6.85%
‪700.00‬
‪‪210.90 K‬‬USD
4
4519Chugai Pharmaceutical Co., Ltd.
6.51%
‪‪4.00 K‬‬
‪‪200.40 K‬‬USD
M
MRKMerck & Co., Inc.
5.21%
‪‪1.91 K‬‬
‪‪160.30 K‬‬USD
G
GILDGilead Sciences, Inc.
5.11%
‪‪1.39 K‬‬
‪‪157.34 K‬‬USD
A
ABBVAbbVie, Inc.
4.96%
‪811.00‬
‪‪152.89 K‬‬USD
P
PFEPfizer Inc.
4.96%
‪‪6.28 K‬‬
‪‪152.64 K‬‬USD
R
ROGRoche Holding Ltd Dividend Right Cert.
4.91%
‪465.00‬
‪‪151.24 K‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.